CRIS - Curis Inc
IEX Last Trade
5.42
-0.090 -1.661%
Share volume: 42,740
Last Updated: Fri 30 Aug 2024 09:57:26 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.51
-0.09
-1.63%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-09 | 2023-03-13 | 2023-05-04 | 2023-08-03 | 2023-11-02 | 2024-02-08 | 2024-05-07 | 2024-08-01 | |
| Assets | |||||||||
| Total Assets | 122.854 M | 108.848 M | 94.544 M | 84.308 M | 89.975 M | 77.282 M | 62.024 M | 50.413 M | |
| Current Assets | 105.717 M | 92.119 M | 78.010 M | 67.851 M | 73.426 M | 60.908 M | 46.066 M | 34.524 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 4.142 M | 3.521 M | 3.937 M | 1.978 M | 2.080 M | 1.780 M | 3.192 M | 3.618 M | |
| Short Term Investments | 4.142 M | 3.521 M | 3.937 M | 1.978 M | 2.080 M | 1.780 M | 3.192 M | 3.618 M | |
| Total Receivables | 2.886 M | 2.975 M | 2.314 M | 2.386 M | 2.848 M | 2.794 M | 2.154 M | 2.546 M | |
| Current Cash | 98.689 M | 85.623 M | 71.759 M | 63.487 M | 68.498 M | 56.334 M | 40.720 M | 28.360 M | |
| Total Non-current Assets | 17.137 M | 16.729 M | 16.534 M | 16.457 M | 16.549 M | 16.374 M | 15.958 M | 15.889 M | |
| Property Plant Equipment | 780.000 K | 689.000 K | 625.000 K | 561.000 K | 497.000 K | 434.000 K | 370.000 K | 308.000 K | |
| Other Assets | 2.022 M | 2.022 M | 2.216 M | 2.539 M | 3.124 M | 3.358 M | 3.358 M | 2.303 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 8.982 M | 8.982 M | 8.982 M | 8.982 M | 8.982 M | 8.982 M | 8.982 M | 8.982 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 122.854 M | 108.848 M | 94.544 M | 84.308 M | 89.975 M | 77.282 M | 62.024 M | 50.413 M | |
| Total liabilities | 67.109 M | 62.296 M | 57.954 M | 58.084 M | 60.384 M | 57.612 M | 52.562 M | 51.107 M | |
| Total current liabilities | 13.742 M | 10.013 M | 8.069 M | 9.682 M | 13.708 M | 13.517 M | 11.303 M | 19.366 M | |
| Accounts Payable | 5.756 M | 3.193 M | 2.642 M | 2.686 M | 5.221 M | 3.172 M | 3.628 M | 2.449 M | |
| Other liabilities | 50.269 M | 49.483 M | 47.393 M | 46.238 M | 44.845 M | 42.606 M | 40.122 M | 29.432 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 50.269 M | 49.483 M | 47.393 M | 46.238 M | 44.845 M | 42.606 M | 40.122 M | 29.432 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 55.745 M | 46.552 M | 36.590 M | 26.224 M | 29.591 M | 19.670 M | 9.462 M | -694.000 K | |
| Common stock | 93.791 M | 96.483 M | 96.614 M | 96.686 M | 5.721 M | 5.787 M | 5.784 M | 5.818 M | |
| Retained earnings | -1.138 B | -1.149 B | -1.161 B | -1.173 B | -1.185 B | -1.196 B | -1.208 B | -1.220 B |